Literature DB >> 11373220

MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.

Y Maetani1, K Itoh, C Watanabe, T Shibata, F Ametani, H Yamabe, J Konishi.   

Abstract

OBJECTIVE: The objective of this study was to determine the MR imaging features of intrahepatic cholangiocarcinoma.
MATERIALS AND METHODS: MR images of 50 patients with pathologically proven intrahepatic cholangiocarcinoma were reviewed retrospectively. T1- and T2-weighted spin-echo images were obtained in all patients. Contrast-enhanced T1-weighted imaging was performed in 25 patients. Signal intensity and enhancement pattern of the tumors were correlated with pathology findings. The frequency of central hypointense regions on T2-weighted images and the intrahepatic bile duct dilatation of several other hepatic tumor types were investigated. Results were compared with imaging results of cholangiocarcinoma.
RESULTS: On T2-weighted images, central hypo- and hyperintense regions were detected in tumors in 27 and 17 patients, respectively. Contrast-enhanced T1-weighted imaging revealed central hypointense areas exhibiting homogeneous, heterogeneous, and no enhancement in six, three, and five, respectively, of 14 patients. Regions of fibrosis displayed enhancement, whereas those of coagulative necrosis showed no enhancement. The signal intensity difference on T2-weighted images between the center and the edge of the tumor correlated well with the fibrotic ratio difference between those two areas corresponding to the MR image (Spearman's rank correlation test, r = 0.72, 95% confidence interval = 0.48-0.86). T2-weighted images revealed central hypointense regions in 16 of 34 instances of hepatic colorectal metastases. However, hypointensity was observed in only 26 of 234 other hepatic tumors. Intrahepatic bile duct dilatation was evident in 27 of 50 cases of cholangiocarcinoma but occurred in only a single case of 34 instances of hepatic colorectal metastases.
CONCLUSION: The combination of the signal intensity on T2-weighted images and the enhancement pattern on contrast-enhanced T1-weighted images showed good correlation with the pathologic findings of cholangiocarcinoma. The occurrence of a central hypointense area on T2-weighted images is not pathognomonic; however, this finding, which reflects severe fibrosis, appears to be a characteristic marker of intrahepatic cholangiocarcinoma. The presence of intrahepatic bile duct dilatation may indicate cholangiocarcinoma, although it is difficult to differentiate cholangiocarcinoma from hepatic colorectal metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373220     DOI: 10.2214/ajr.176.6.1761499

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  40 in total

1.  Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography.

Authors:  Thomas J Vogl; Wolfram O Schwarz; Matthias Heller; Christopher Herzog; Stephan Zangos; Rainer E Hintze; Peter Neuhaus; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

2.  Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.

Authors:  Ting Ni; Xiao-Sha Shang; Wen-Tao Wang; Xin-Xing Hu; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

3.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 4.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

Review 5.  Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

Authors:  Eugene J Koay; Bruno C Odisio; Milind Javle; Jean-Nicolas Vauthey; Christopher H Crane
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

6.  Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.

Authors:  H-X Xu; L-D Chen; L-N Liu; Y-F Zhang; L-H Guo; C Liu
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

Review 7.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

Review 8.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

9.  Contrast-enhanced ultrasound appearances of enhancement patterns of intrahepatic cholangiocarcinoma: correlation with pathological findings.

Authors:  Francesco Loria; Giuseppe Loria; Salvatore Basile; Giuseppe Crea; Luciano Frosina; Isidoro Di Carlo
Journal:  Updates Surg       Date:  2014-05-07

Review 10.  Cross-sectional imaging of biliary tumors: current clinical status and future developments.

Authors:  Christoph J Zech; Stefan O Schoenberg; Maximilian Reiser; Thomas Helmberger
Journal:  Eur Radiol       Date:  2004-04-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.